CEACAM5 and non-small cell lung carcinoma: Our results discovered that ALP and CA125, CEA, and CYFRA21-1 levels were raised in the serum of NSCLC patients and further enhanced in NSCLC patients in relatively advanced stage relative to NSCLC patients in the early stage.